JP2022512922A5 - - Google Patents
Info
- Publication number
- JP2022512922A5 JP2022512922A5 JP2021524069A JP2021524069A JP2022512922A5 JP 2022512922 A5 JP2022512922 A5 JP 2022512922A5 JP 2021524069 A JP2021524069 A JP 2021524069A JP 2021524069 A JP2021524069 A JP 2021524069A JP 2022512922 A5 JP2022512922 A5 JP 2022512922A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- transmembrane domain
- car
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862756294P | 2018-11-06 | 2018-11-06 | |
| US62/756,294 | 2018-11-06 | ||
| US201962788440P | 2019-01-04 | 2019-01-04 | |
| US62/788,440 | 2019-01-04 | ||
| PCT/US2019/060005 WO2020097164A1 (en) | 2018-11-06 | 2019-11-06 | Chimeric antigen receptor memory-like (carml) nk cells and methods of making and using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022512922A JP2022512922A (ja) | 2022-02-07 |
| JP2022512922A5 true JP2022512922A5 (https=) | 2022-11-14 |
Family
ID=70612473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021524069A Pending JP2022512922A (ja) | 2018-11-06 | 2019-11-06 | キメラ抗原受容体記憶様（ｃａｒｍｌ）ｎｋ細胞ならびにその産生および使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220073585A1 (https=) |
| EP (1) | EP3876961A4 (https=) |
| JP (1) | JP2022512922A (https=) |
| KR (1) | KR20210090220A (https=) |
| CN (1) | CN113423409A (https=) |
| AU (1) | AU2019377461A1 (https=) |
| CA (1) | CA3117206A1 (https=) |
| IL (1) | IL282850A (https=) |
| SG (1) | SG11202104287RA (https=) |
| WO (1) | WO2020097164A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3120563A1 (en) | 2018-11-26 | 2020-06-04 | Nkarta, Inc. | Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy |
| EP3773918A4 (en) | 2019-03-05 | 2022-01-05 | Nkarta, Inc. | CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY |
| US11459372B2 (en) | 2020-11-30 | 2022-10-04 | Crispr Therapeutics Ag | Gene-edited natural killer cells |
| WO2022144632A1 (en) | 2020-12-30 | 2022-07-07 | Crispr Therapeutics Ag | Compositions and methods for differentiating stem cells into nk cells |
| JP2024504728A (ja) * | 2021-01-26 | 2024-02-01 | サイトケアズ （シャンハイ） インコーポレイテッド | キメラ抗原受容体（ｃａｒ）構築物およびｃａｒ構築物を発現するｎｋ細胞 |
| WO2022171179A1 (zh) * | 2021-02-10 | 2022-08-18 | 苏州克睿基因生物科技有限公司 | 一种扩增增强子及其应用 |
| US20230330228A1 (en) | 2022-03-22 | 2023-10-19 | WUGEN, Inc. | Hybrid promoters, vectors containing same and methods of use |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130266551A1 (en) * | 2003-11-05 | 2013-10-10 | St. Jude Children's Research Hospital, Inc. | Chimeric receptors with 4-1bb stimulatory signaling domain |
| CN103946952A (zh) * | 2011-09-16 | 2014-07-23 | 宾夕法尼亚大学董事会 | 用于治疗癌症的rna改造的t细胞 |
| EP2948544A4 (en) * | 2013-01-28 | 2016-08-03 | St Jude Childrens Res Hospital | CHIMERIC RECEPTOR WITH NKG2D SPECIFICITY FOR CELL THERAPY AGAINST CANCER AND INFECTION DISEASES |
| AU2015244039B2 (en) * | 2014-04-07 | 2021-10-21 | Novartis Ag | Treatment of cancer using anti-CD19 chimeric antigen receptor |
| BR112017001183A2 (pt) * | 2014-07-21 | 2017-11-28 | Novartis Ag | tratamento de câncer usando receptor de antígeno quimérico anti-bcma humanizado |
| BR112017005631A2 (pt) * | 2014-09-19 | 2018-06-26 | City Of Hope | células t com receptor de antígeno coestimulador quimérico direcionadas à il13ra2 |
| JP6849600B6 (ja) * | 2015-01-29 | 2021-06-30 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | キメラ抗原受容体、組成物及び方法 |
| EP3548049A4 (en) * | 2016-12-05 | 2020-07-22 | Fate Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR MODULATION OF IMMUNE CELLS IN ADOPTIVE IMMUNOTHERAPIES |
| CA3057838A1 (en) * | 2017-03-24 | 2018-09-27 | Lentigen Technology, Inc. | Compositions and methods for treating cancer with anti-cd33 immunotherapy |
| US11771718B2 (en) * | 2017-10-18 | 2023-10-03 | Precigen, Inc. | Polypeptide compositions comprising spacers |
| CN108219004A (zh) * | 2018-02-08 | 2018-06-29 | 吉林省拓华生物科技有限公司 | 双特异嵌合抗原受体修饰的t细胞、其制备方法及用途 |
| EP4021485A1 (en) * | 2019-08-28 | 2022-07-06 | King's College London | B cell targeted parallel car (pcar) therapeutic agents |
-
2019
- 2019-11-06 AU AU2019377461A patent/AU2019377461A1/en not_active Abandoned
- 2019-11-06 US US17/291,959 patent/US20220073585A1/en active Pending
- 2019-11-06 CA CA3117206A patent/CA3117206A1/en active Pending
- 2019-11-06 CN CN201980088089.2A patent/CN113423409A/zh active Pending
- 2019-11-06 SG SG11202104287RA patent/SG11202104287RA/en unknown
- 2019-11-06 WO PCT/US2019/060005 patent/WO2020097164A1/en not_active Ceased
- 2019-11-06 JP JP2021524069A patent/JP2022512922A/ja active Pending
- 2019-11-06 KR KR1020217017370A patent/KR20210090220A/ko not_active Ceased
- 2019-11-06 EP EP19882787.5A patent/EP3876961A4/en not_active Withdrawn
-
2021
- 2021-05-02 IL IL282850A patent/IL282850A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022512922A5 (https=) | ||
| US20240093232A1 (en) | Retroviral And Lentiviral Vectors | |
| JP2024507996A5 (https=) | ||
| JP2025031794A5 (https=) | ||
| JP6695347B2 (ja) | レトロウイルスおよびレンチウイルスベクター | |
| JP2018526033A5 (https=) | ||
| FI3844267T3 (fi) | Menetelmät kimeeristä antigeenireseptoria ilmentävien solujen valmistamiseksi | |
| BR112020007710A2 (pt) | métodos para produzir células que expressam receptor de antígeno quimérico | |
| CN106574246A (zh) | 用于细胞免疫治疗的方法和组合物 | |
| Rosenzweig et al. | In vitro T lymphopoiesis of human and rhesus CD34+ progenitor cells | |
| JP2021500905A5 (https=) | ||
| JP2024525609A5 (https=) | ||
| EP3753566A1 (en) | All-in one viral vector for car and therapeutic effector molecule | |
| CN117677633A (zh) | 基于nkg2d的嵌合抗原受体 | |
| CA3120364A1 (en) | Placenta-derived allogeneic car-t cells and uses thereof | |
| CN115835873A (zh) | 用于产生表达重组受体的供体分批细胞的方法 | |
| US20240368626A1 (en) | T-cell manufacturing methods | |
| CN110863014A (zh) | 改进的慢病毒载体 | |
| Ruddle | T cell hybrids with specificity for individual antigens | |
| AU2023275895A1 (en) | Artificial immune receptors | |
| RU2021116146A (ru) | Nk-клетки с химерным антигенным рецептором, подобные клеткам памяти (carml), и способы их получения и примения | |
| Bostik et al. | Innate immune natural killer cells and their role in HIV and SIV infection | |
| CN109207501A (zh) | 表达通用型嵌合抗原受体的序列的构建方法 | |
| CN119137262A (zh) | 经改造细胞及使用方法 | |
| Pacheco-Castro et al. | Herpesvirus saimiri immortalization of αβ and γδ human T-lineage cells derived from CD34+ intrathymic precursors in vitro |